Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-08-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第六届董事会第三次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the sixth board of directors' third meeting of 嘉事堂药业股份有限公司. It includes approval of the 2019 semi-annual report and a change in accounting policy. The document states that the full semi-annual report is available on the company's designated information disclosure website and media, indicating that this document itself is not the full report but an announcement of the board meeting decisions and references to the report. The document length is short (1039 characters), and it primarily serves as a formal announcement of meeting resolutions rather than containing the full financial report or detailed financial data. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for such announcements that do not contain the full report or detailed financial data.
2019-08-21 Chinese
2019年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '嘉事堂药业股份有限公司 2019 年半年度财务报告' which translates to 'Jia Shi Tang Pharmaceutical Co., Ltd. 2019 Semi-Annual Financial Report'. The content includes detailed financial statements such as consolidated balance sheets, profit statements, cash flow statements, notes on accounting policies, tax information, and detailed notes on financial statement items. The presence of comprehensive financial data and analysis for a half-year period clearly indicates this is an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements rather than just an announcement or certification. Therefore, the correct classification is 'IR' for Interim / Quarterly Report with high confidence. H1 2019
2019-08-21 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding a change in accounting policies. It references specific regulatory notices from the Ministry of Finance in China about revisions to financial statement formats for the year 2019. The document details the nature of the accounting policy changes, their impact on financial statement presentation, and includes approvals from the board, supervisory board, and independent directors. The document length is 3016 characters, which is relatively short and primarily serves as an announcement rather than containing full financial statements or detailed financial analysis. It does not present a full annual or interim report, nor is it a certification or a voting result. Therefore, it fits best as a Regulatory Filing (RNS) because it is a formal regulatory announcement about accounting policy changes without the full financial data of a report.
2019-08-21 Chinese
2019年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '嘉事堂药业股份有限公司 2019 年半年度报告全文' which translates to 'Cachet Pharmaceutical Co., Ltd. 2019 Semi-Annual Report Full Text'. It explicitly states it is a half-year report covering the period from January 1, 2019 to June 30, 2019. The content includes detailed financial data, business overview, management discussion and analysis, financial statements, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There are no indications that this is an announcement of a report publication or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2019
2019-08-21 Chinese
关于参加北京辖区深市上市公司投资者集体接待日活动的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the company's participation in an investor collective reception day event organized by a stock exchange association and a network company. It mentions the date and format of the event, and that company executives will communicate with investors on various topics including governance, strategy, operations, financing plans, and sustainability. There is no financial data, no report attached or published, and no mention of voting results or regulatory filings. The document is clearly an announcement of an investor event, not a report or transcript. Therefore, the best fitting category is Investor Presentation (IP), as it is a detailed presentation for investors focusing on company information and strategy.
2019-07-11 Chinese
关于控股股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding the release of pledged shares by a major shareholder. It details the shareholder's name, the number of shares released from pledge, and the status of pledged shares. There is no financial data, no report attached or referenced as being published, and no mention of a meeting or voting results. The content fits the description of a Major Shareholding Notification, as it informs about changes in significant share ownership or share pledging status. The document length is short and focused solely on share pledge release, which aligns with the MRQ category rather than a full report or other announcement types.
2019-07-10 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.